Steve Foots, Chief Executive Officer, exercised 27,209 shares in the company on the 9th March 2020 at a price of 0.00p. The Director now holds...

Steve Foots, Chief Executive Officer, sold post-exercise 12,814 shares in the company on the 10th March 2020 at a price of 4483.84p. The Director now...

Keith Layden, Non Executive Director, exercised 3,241 shares in the company on the 9th March 2020 at a price of 0.00p. The Director now holds...

RBC Capital Markets today reaffirms its sector performer investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 2530p (from 2500p).

Broker...

David Atkins, Chief Executive Officer, exercised 59,985 shares in the company on the 12th March 2020 at a price of 0.00p. The Director now holds...

David Atkins, Chief Executive Officer, sold post-exercise 28,251 shares in the company on the 12th March 2020 at a price of 157.20p. The Director now...

RBC Capital Markets today upgrades its investment rating on G4S PLC (LON:GFS) to outperform (from sector performer) and cut its price target to 130p (from...

Credit Suisse today reaffirms its underperform investment rating on Ashmore Group PLC (LON:ASHM) and cut its price target to 390p (from 440p).

Broker Forecasts data...

Brian May, Non Executive Director, bought 25,000 shares in the company on the 12th March 2020 at a price of 160.36p. The Director now holds...

Margaret Ewing, Non Executive Director, bought 10,000 shares in the company on the 12th March 2020 at a price of 160.83p. The Director now holds...